SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

08 Feb 2024 Evaluate
The sales moved up 45.90% to Rs. 3928.28 millions for the December 2023 quarter as compared to Rs. 2692.50 millions during the year-ago period.Net Profit witnessed a 165.16% growth almost the double from Rs. 304.35 millions to Rs. 807.01  millions  of same quarter last year.Operating profit for the quarter ended December 2023 rose to 1226.65 millions as compared to 548.76 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 3928.28 2692.50 45.90 11735.71 7841.26 49.67 11911.98 9510.77 25.25
Other Income 21.01 9.33 125.19 71.88 16.84 326.84 97.48 20.77 369.33
PBIDT 1226.65 548.76 123.53 3623.15 1532.75 136.38 2810.56 1442.71 94.81
Interest 37.41 27.45 36.28 103.88 87.78 18.34 130.67 134.94 -3.16
PBDT 1189.24 521.31 128.13 3519.27 1444.97 143.55 2679.89 1307.77 104.92
Depreciation 151.44 133.36 13.56 432.38 393.06 10.00 527.76 490.36 7.63
PBT 1037.80 387.95 167.51 3086.89 1051.91 193.46 2152.13 817.41 163.29
TAX 230.79 83.60 176.06 766.99 265.81 188.55 520.94 182.06 186.14
Deferred Tax -21.99 17.38 -226.52 -9.63 15.27 -163.06 17.04 -22.16 -176.90
PAT 807.01 304.35 165.16 2319.90 786.10 195.12 1631.19 635.35 156.74
Equity 129.00 129.00 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 31.23 20.38 53.21 30.87 19.55 57.94 23.59 15.17 55.54

Neuland Laboratories Share Price

14408.95 -539.25 (-3.61%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×